Published on 17 Feb 2024 on Simply Wall St. via Yahoo Finance
Key Insights
The considerable ownership by individual investors in G1 Therapeutics indicates that they collectively have a greater say in management and business strategy35% of the business is held by the top 25 shareholders Recent sales by insiders
To get a sense of who is truly in control of G1 Therapeutics, Inc. (NASDAQ:GTHX), it is important to understand the ownership structure of the business. With 60% stake, individual investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.